Wake Research Associates, LLC /ID# 154880

3100 Duraleigh Road
Raleigh, North Carolina 27612

We've found

1 trials

at this facility

A Study of the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Raleigh, NC

Use our guide to learn which trials are right for you!